Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development

EBioMedicine(2020)10.1016/j.ebiom.2020.102743Source: DataRank Database

Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development is a research paper published in EBioMedicine (2020). On theSindex it has a DataRank of 0. It has been cited 416 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access416 citations

Download PDF

Cite:

Linked data & code

gen nct pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 27.16)OA: goldTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Géza Erdös ORCID,Shaohua Huang ORCID,Thomas W. Kenniston,Stephen C. Balmert ORCID,Cara Donahue Carey ORCID

Live enrichment

PubMed:32249203 PMC:PMC7128973 OpenAlex:https://openalex.org/W3013541100

NIH NIAID

Grant: R21-AI114264

NIH NIAMS

Grant: R01-AR074285

NIH NIAMS

Grant: R01-AR071277

NIH NIAMS

Grant: R01-AR068249

NIH National Cancer Institute

Grant: T32-CA175294

NCI NIH HHS

Grant: T32 CA175294

NIAMS NIH HHS

Grant: R01 AR068249

NIAMS NIH HHS

Grant: R01 AR074285

NIAID NIH HHS

Grant: R21 AI114264

NIAMS NIH HHS

Grant: R01 AR071277

FWCI

27.16

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttp://www.thelancet.com/article/S2352396420301183/pdf

publisherhttp://www.thelancet.com/article/S2352396420301183/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2352396420301183?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352396420301183?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ebiom.2020.102743

Fields of Study

Advancements in Transdermal Drug DeliverySARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune Responses

MeSH Terms

BetacoronavirusSARS-CoV-2COVID-19 VaccinesAdjuvants, ImmunologicAnimalsAntibodies, ViralFemaleImmunoglobulin GImmunization, SecondaryInjections, SubcutaneousMice, Inbred BALB CMice, Inbred C57BLRecombinant Fusion ProteinsSpecific Pathogen-Free OrganismsTime FactorsViral VaccinesCoronavirus InfectionsVaccines, SubunitMiceSpike Glycoprotein, CoronavirusMiddle East Respiratory Syndrome Coronavirus

Keywords

ImmunogenicityVirologyMiddle East respiratory syndrome coronavirusCoronavirusImmune systemMedicineTLR5Middle East respiratory syndromeVirusImmunologyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Innate immune systemDiseaseToll-like receptorSubunit vaccinesMicroneedle ArrayTrimerizationCovid-19Sars-cov-2Mers-cov S1

Sustainable Development Goals

SDG 0: Good health and well-being